8:00 - 19:00

Working hours MON. - FRI.

Too cold to handle? Race is on to pioneer shipping of hydrogen By Reuters

By Jonathan Saul LONDON (Reuters) - Hydrogen is touted as an inevitable green fuel of the future. Tell that to the people who'll have to ship it across the globe at hyper-cold temperatures close to those in outer space. Yet that is exactly what designers are attempting to do. In the biggest technological challenge for merchant shipping in decades, companies are beginning to develop a new generation of vessels that can deliver hydrogen to heavy industry, betting plants worldwide will convert to the fuel and propel the transition to a lower-carbon economy. There are...

Continue reading

Canadian province of Ontario will pause first doses of AstraZeneca vaccine By Reuters

TORONTO (Reuters) - The Canadian province of Ontario will stop offering first doses of AstraZeneca (NASDAQ:AZN)'s COVID-19 vaccine because of evidence that the risk of rare blood clots is somewhat higher than previously estimated, provincial officials said on Tuesday. "This decision was made out of an abundance of caution due to an observed increase in the rare blood clotting known as vaccine-induced immune thrombotic thrombocytopenia," said Chief Medical Officer David Williams (NYSE:WMB). "We are reviewing the data to consider options for the use of AstraZeneca for second doses and more broadly moving forward." ...

Continue reading

Two Canadian provinces stop offering AstraZeneca’s COVID vaccine By Reuters

By Allison Martell and Nia Williams (NYSE:WMB) CALGARY, Alberta (Reuters) - The Canadian provinces of Alberta and Ontario said on Tuesday they would stop offering first doses of AstraZeneca (NASDAQ:AZN)'s COVID-19 vaccine, with Ontario citing evidence that the risk of rare blood clots is somewhat higher than previously estimated. Alberta said it took the same step only because it was unclear when more shipments of the vaccine might arrive, and not due to concern about side effects. Officials in Ontario said roughly one in 60,000 people who received the vaccine in the province, eight in total,...

Continue reading

Pfizer asks UK regulator to approve vaccine for teenagers -The Telegraph By Reuters

(Reuters) -Pfizer Inc has formally asked the UK medical regulator for permission to use its COVID-19 vaccine for 12-to 15-year olds in Britain, the Telegraph reported on Tuesday. "We can confirm that the companies have submitted a request to the MHRA to expand the use of the Pfizer/BioNTech Covid vaccine in the UK to adolescents, the report said, citing a Pfizer (NYSE:PFE) spokesman. Pfizer and the MHRA did not immediately response to Reuters requests for comment. The move comes as U.S. regulators on Monday authorized Pfizer and BioNTech's COVID-19 vaccine for use in...

Continue reading

Advisory firm PIRC slams Shell on climate strategy before AGM By Reuters

By Ron Bousso LONDON (Reuters) -Shareholder advisory PIRC recommended investors vote against Shell (LON:RDSa)'s non-binding resolution on its energy transition strategy on Tuesday, setting up a showdown at its annual general meeting next week. The Pensions & Investment Research Consultants (PIRC), a major proxy advisory, said Royal Dutch Shell's strategy to cut emissions "does not seem to have a clear plan for the competitive aspects of the energy transition". PIRC joins calls by several investors and activists opposing Shell's strategy, which has nevertheless won support of major investors that are part the Climate Action 100+ group....

Continue reading

Private-equity backed Atlantic Nickel hires banks to explore options – sources By Reuters

LONDON (Reuters) - Atlantic Nickel, a Brazilian miner backed by London private equity mining fund Appian Capital Advisory has hired investment banks to explore sale options, capitalising on the increasing demand for metals used in electric batteries, three sources said. Its sale process with Citi and Standard Chartered (LON:STAN) is the most advanced, with potential buyers currently working on first-round bids, the sources added. The company's meetings with Canadian banks RBC Capital Markets and Bank of Montreal (BOM) focused on exploring a listing, possibly in Toronto, while Goldman Sachs (NYSE:GS) is working on...

Continue reading

Bank of England warns over easy alternatives to Libor By Reuters

By Huw Jones LONDON (Reuters) - Markets must not replace the tarnished Libor interest rate with alternatives that could end up replicating the same flaws that made it easy for banks to manipulate, Bank of England Governor Andrew Bailey said on Tuesday. The London Interbank Offered Rate is being scrapped at the end of December, though the publication of some dollar denominations continue until mid-2023 for outstanding contracts. "I am pleased we have made a lot of progress and I am very optimistic that we will be there," Bailey told an online event. Regulators want Libor...

Continue reading

Colonial Pipeline says corporate website back online By Reuters

(Reuters) -Colonial Pipeline's corporate website was back online on Tuesday after a temporary service disruption unrelated to the ransomware cyberattack against the U.S. energy company, it said on Twitter. The website started experiencing interruptions by Monday night and then went down for more than 10 hours as the operator of the largest fuel pipeline in the United States deals with a cybersecurity attack that shut its entire network on Friday. The Alpharetta, Georgia-based company said it was continuing to make progress on its system restart plan. Colonial's 5,500-mile (8,850-km) pipeline network carries nearly...

Continue reading

Oprah-backed Oatly seeks $10 billion valuation in U.S. IPO By Reuters

(Reuters) - Oprah Winfrey-backed vegan milk maker Oatly is aiming for a valuation of about $10 billion in a U.S. initial public offering, following increasing consumer demand for plant-based dairy. The company, whose investors also include rapper Jay Z and former Starbucks Corp (NASDAQ:SBUX) head Howard Schultz, plans to offer nearly 65 million American Depositary Shares and an additional 20 million shares from existing shareholders priced between $15 and $17 apiece, according to a regulatory filing on Tuesday. The company plans to raise about $1.43 billion through the IPO. The plant-based food sector...

Continue reading

Novavax Down Second Straight Day On Concerns About Delays By Investing.com

By Dhirendra Tripathi Investing.com – Novavax (NASDAQ:NVAX) extended losses for the second consecutive day, plunging 12% in Tuesday’s trade a day after the vaccine maker said it is pushing back its timetable for seeking regulatory approvals for its Covid-19 shot. The company said it intended to apply for permissions in the U.S, the U.K. and Europe in the next quarter. Cumulatively, Novavax share price is now down by more than half of its year’s high of $331. Market makers are puzzled by the continuing delay at the company’s end at a time...

Continue reading
en_GBEnglish